Commentary letter on "Revitalizing monoamine oxidase inhibitors: a call for action"

CNS Spectr. 2020 Aug;25(4):458-459. doi: 10.1017/S1092852919001378. Epub 2019 Oct 30.

Authors

Carlo Ignazio Cattaneo¹, Michele Fornaro², Francesca Vittoria Ressico¹, Giulio Perugi³

Affiliations

¹ Department of Mental Health, ASL NOVARA, Novara, Italy.
² Neuroscience, Reproductive Science and Odontostolmatology, Section of Psychiatry, University School of Medicine Federico II, Naples, Italy.
³ Clinica Psichiatrica, Dipartimento di Medicina Sperimentale- Pisa, University of Pisa, Tuscany, Italy.

PMID: 31663496
DOI: 10.1017/S1092852919001378

No abstract available

Keywords: ECT; Monoamine oxidase inhibitors; antidepressant.; major depression; treatment resistant depression.

Publication types

Letter
Comment

MeSH terms

Antidepressive Agents / therapeutic use
Depressive Disorder* / drug therapy
Humans
Monoamine Oxidase Inhibitors* / adverse effects

Substances

Antidepressive Agents
Monoamine Oxidase Inhibitors